Contribution to the Project on Cervical Cancer Prevention in Moldova
In Moldova, the cervical cancer incidence and mortality of women continues to be high due to very high proportion of late stage diagnoses. An integrated approach to cervical cancer prevention and control combining vaccination and regular cervical screening has the potential to reduce cervical cancer deaths by at least 80%. The project aims at reducing incidence and mortality due to cervical cancer through better access to and use of cost-effective and quality services within organized cervical cancer prevention program.
- Women and adolescent girls have better access to quality cervical screening services and HPV (Human Papillomavirus) vaccination
- Women and adolescent girls have increased awareness and knowledge of the benefit of cervical screening and HPV vaccination
- National normative framework to enable the effective Operation of cervical cancer prevention services is reviewed and updated
- National quality assurance guidelines and standards for cervical screening services are revised, approved and used
- Technical capacity of healthcare facilities involved in cervical screening is strengthened in compliance with international evidence-based standards
- Knowledge and skills of health personnel to provide quality cervical screening services and HPV vaccination are improved
- National coordination, monitoring and evaluation of cervical screening, based on reliable data, are strengthened
- Comprehensive approach is applied to increase awareness and knowledge of women and adolescent girls and improve their healthcare seeking behavior and demand for cervical screening and HPV vaccination
- United Nations Population Fund
In Moldova, cancer mortality is high, accounting for 14% of all deaths. This is especially true for cervical cancer incidence (15.6 per 100'000 population) and mortality (8.1/100'000). Recent assessments (2014, 2016) concluded that cervical screening is conducted opportunistically. The screening's impact on cervical cancer rates is low, as it is implemented without proper staff training, standardization of procedures, integrated delivery of health services, effective patient management, or quality assurance.
The incidence and mortality of Moldovan women attributable to cervical cancer is reduced.
Family doctors, rnedical assistants/nurses, gynaecologists, and pathologists from different healthcare institutions, including from Transnistria region, as well as representatives of Ministry of Health, National Health Insurance Company, National Centre of Health Management, and medical education institutions responsible for undergraduate, graduate, postgraduate, and continuing professional education. Final project beneficiaries are all women and girls from Moldovan population, including 761'504 women aged 25-61 years (target population eligible for cervical screening), and 14'387 girls aged 10 years (target population for HPV vaccination).
Resultate von früheren Phasen:
The collaboration between SDC and UNFPA started in 2016, with a project on strengthening cervical screening capacities of primary health care providers. With SDC support, 406 primary health care professionals (69 family doctors and 337 nurses) selected from 19 districts, have been trained. Previously, UNFPA facilitated the training of 12 Moldovan prirnary health care specialists as trainers. Also, several other specialists (cytologists, pathologists and gynaecologists) have benefited from short trainings (1-3 months) in international centres.
Organisation der Vereinten Nationen (UNO)
|Koordination mit anderen Projekten und Akteuren||
The project will receive additional support from WHO/GAVI, International Association for Cervical cancer prevention and Ministry of Health. lt will be implemented in synergy with ongoing SDC supported projects that integrate health and social care (Healthy Life, Healthy Generation, Mental Health projects).
|Budget||Laufende Phase Schweizer Beitrag CHF 600'000 Bereits ausgegebenes Schweizer Budget CHF 590'000|
|Projektphasen||Phase 1 01.07.2017 - 31.12.2020 (Laufende Phase)|